VASOGLIF 10 MG COM REV CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1557300730021 -
GGREM
537526090014607 -
Código de barras
7898587902304
O que a fonte publica
- Detentor do registro
- TEVA FARMACÊUTICA LTDA.
- Princípios ativos
- DAPAGLIFLOZINA
- Embalagem
- 10 MG COM REV CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "VASOGLIF 10 MG COM REV CT BL AL AL X 30",
"holder": "TEVA FARMACÊUTICA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898587902304"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "537526090014607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "05.333.542/0001-08",
"priceRegime": "Regulado",
"productName": "VASOGLIF",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "10 MG COM REV CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "131.24",
"icms-12": "149.14",
"icms-17": "158.12",
"icms-18": "160.05",
"icms-19": "162.02",
"icms-20": "164.05",
"icms-21": "166.13",
"icms-22": "168.26",
"icms-23": "170.44",
"icms-17.5": "159.08",
"icms-19.5": "163.03",
"icms-20.5": "165.08",
"icms-22.5": "169.34",
"icms-12-alc": "147.35",
"icms-17-alc": "156.22",
"icms-18-alc": "158.13",
"icms-19-alc": "160.08",
"icms-20-alc": "162.08",
"icms-21-alc": "164.13",
"icms-22-alc": "166.24",
"icms-23-alc": "168.40",
"withoutTaxes": "129.67",
"icms-17.5-alc": "157.17",
"icms-19.5-alc": "161.07",
"icms-20.5-alc": "163.10",
"icms-22.5-alc": "167.31"
},
"pisCofinsList": "Positiva",
"substanceText": "DAPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "180.90",
"icms-12": "205.57",
"icms-17": "217.95",
"icms-18": "220.61",
"icms-19": "223.33",
"icms-20": "226.13",
"icms-21": "228.99",
"icms-22": "231.93",
"icms-23": "234.93",
"icms-17.5": "219.28",
"icms-19.5": "224.72",
"icms-20.5": "227.55",
"icms-22.5": "233.42",
"icms-12-alc": "203.70",
"icms-17-alc": "215.96",
"icms-18-alc": "218.61",
"icms-19-alc": "221.30",
"icms-20-alc": "224.07",
"icms-21-alc": "226.90",
"icms-22-alc": "229.82",
"icms-23-alc": "232.80",
"withoutTaxes": "179.25",
"icms-17.5-alc": "217.28",
"icms-19.5-alc": "222.67",
"icms-20.5-alc": "225.48",
"icms-22.5-alc": "231.30"
},
"invalidBarcodes": [],
"activeSubstances": [
"DAPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1557300730021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:537526090014607"